BioNTech CEO Ugur Sahin disposes of $5,935,923 of common shares
BNTX•Ugur Sahin disclosed sales of 63,209 BioNTech ordinary shares on Oct. 8-9, 2026, for prices ranging from $92.3142 to $95.3733. His directly held shares fell to zero; he continued to report 39,218,111 shares held indirectly.
1. Share sales disclosed
BioNTech CEO Ugur Sahin disclosed sales of 63,209 ordinary shares on Oct. 8-9, 2026, at prices ranging from $92.3142 to $95.3733. Direct holdings fell to zero following the transactions, while indirect holdings remained at 39,218,111 shares. The trades were executed under a Rule 10b5-1 plan adopted on June 3, 2026.
